Geoffrey Richard Heintzelman

This inventor holds 12 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignee: Aerie Pharmaceuticals, Inc.. Active years: 2010-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Geoffrey Richard Heintzelman. Retrieved from https://idiyas.com/inventor/geoffrey-richard-heintzelman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 1)

% Patents Active = 91.7

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 4.0

ph-index = 9

Forward Citations = 360(Granted Patents)

Company Filing History:

12 out of 60

Aerie Pharmaceuticals, Inc.

patents

Years Active: 2010-2021

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10899714 - 6-aminoisoquinoline compounds (2021-01-26),

2. 10472327 - 6-aminoisoquinoline compounds (2019-11-12),

3. 9890123 - 6-aminoisoquinoline compounds (2018-02-13),

4. 9365518 - 6-aminoisoquinoline compounds (2016-06-14),

5. 8921392 - 6-aminoisoquinoline compounds (2014-12-30),

6. 8871757 - 6-and 7-amino isoquinoline compounds and methods for making and using the same (2014-10-28),

7. 8455647 - 6-aminoisoquinoline compounds (2013-06-04),

8. 8455514 - 6-and 7-amino isoquinoline compounds and methods for making and using the same (2013-06-04),

9. 8455513 - 6-aminoisoquinoline compounds (2013-06-04),

10. 8357699 - 6-aminoisoquinoline compounds (2013-01-22),

11. 8034943 - 6-aminoisoquinoline compounds (2011-10-11),

12. 7671205 - 6-aminoisoquinoline compounds (2010-03-02),

Title: Innovations of Geoffrey Richard Heintzelman

Introduction

Geoffrey Richard Heintzelman is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on 6-aminoisoquinoline compounds. With a total of 12 patents to his name, Heintzelman has established himself as a key figure in the development of therapeutic solutions for various health conditions.

Latest Patents

His latest patents focus on 6-aminoisoquinoline compounds, which are designed to influence, inhibit, or reduce the action of a kinase. These compounds are crucial in the formulation of pharmaceutical compositions that include therapeutically effective amounts of the 6-aminoisoquinoline compounds along with pharmaceutically acceptable carriers. The methods developed using these compounds aim to address disease states or conditions such as cancer, obesity, and glaucoma.

Career Highlights

Heintzelman is currently associated with Aerie Pharmaceuticals, Inc., where he continues to innovate and contribute to the pharmaceutical industry. His work has not only advanced scientific understanding but has also paved the way for new treatment options for patients suffering from serious health issues.

Collaborations

Some of his notable coworkers include Mitchell Anthony deLong and Jill Marie Sturdivant, who have collaborated with him on various projects within the company.

Conclusion

Geoffrey Richard Heintzelman's contributions to the field of pharmaceuticals through his patents and innovative work on 6-aminoisoquinoline compounds highlight his importance as an inventor. His ongoing efforts continue to impact the medical community positively.

Profile summary based on public USPTO records.